SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Jeanette M. Tetrault, Janet P. Tate, Kathleen A. McGinnis, Joseph L. Goulet, Lynn E. Sullivan, Kendall Bryant, Amy C. Justice, David A. Fiellin, Hepatic Safety and Antiretroviral Effectiveness in HIV-Infected Patients Receiving Naltrexone, Alcoholism: Clinical and Experimental Research, 2012, 36, 2
  2. 2
    Nicholas T. Bello, Zachary W. Patinkin, Timothy H. Moran, Opioidergic consequences of dietary-induced binge eating, Physiology & Behavior, 2011, 104, 1, 98

    CrossRef

  3. 3
    Gihyun Yoon, Suck Won Kim, Paul Thuras, Joseph Westermeyer, Safety, tolerability, and feasibility of high-dose naltrexone in alcohol dependence: an open-label study, Human Psychopharmacology: Clinical and Experimental, 2011, 26, 2
  4. 4
    Gerardo González, Mauricio Romero-González, Alternativas farmacológicas para el tratamiento de la dependencia a la heroína: un nuevo reto en Colombia, Revista Colombiana de Psiquiatría, 2010, 39, 188S

    CrossRef

  5. 5
    Mary M. Hagan, Peptide YY: a key mediator of orexigenic behavior, Peptides, 2002, 23, 2, 377

    CrossRef

  6. 6
    Mark K. Greenwald, Maxine L. Stitzer, Antinociceptive, subjective and behavioral effects of smoked marijuana in humans, Drug and Alcohol Dependence, 2000, 59, 3, 261

    CrossRef

  7. 7
    G. Gerra, A. Zaimovic, P. Rustichelli, B. Fontanesi, U. Zambelli, M. Timpano, C. Bocchi, R. Delsignore, Rapid opiate detoxication in outpatient treatment, Journal of Substance Abuse Treatment, 2000, 18, 2, 185

    CrossRef

  8. 8
    Kenzie L. Preston, Kenneth Silverman, Annie Umbricht, Anna DeJesus, Ivan D. Montoya, Charles R. Schuster, Improvement in naltrexone treatment compliance with contingency management, Drug and Alcohol Dependence, 1999, 54, 2, 127

    CrossRef